Daiwa Securities Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-481
| Closed | -$38K | – | 1307 |
|
|
2025
Q4 | $38K | Sell |
481
-24,220
| -98% | -$1.82M | ﹤0.01% | 1133 |
|
|
2025
Q3 | $1.62M | Sell |
24,701
-1,440
| -6% | -$70.3K | 0.01% | 679 |
|
|
2025
Q2 | $1.03M | Buy |
26,141
+4,000
| +18% | +$131K | ﹤0.01% | 744 |
|
|
2025
Q1 | $667K | Buy |
22,141
+21,600
| +3,993% | +$707K | ﹤0.01% | 781 |
|
|
2024
Q4 | $19K | Hold |
541
| – | – | ﹤0.01% | 1086 |
|
|
2024
Q3 | $22K | Hold |
541
| – | – | ﹤0.01% | 1096 |
|
|
2024
Q2 | $26K | Hold |
541
| – | – | ﹤0.01% | 1123 |
|
|
2024
Q1 | $23K | Sell |
541
-46
| -8% | -$2.19K | ﹤0.01% | 1133 |
|
|
2023
Q4 | $30K | Buy |
587
+72
| +14% | +$3.45K | ﹤0.01% | 1104 |
|
|
2023
Q3 | $23K | Hold |
515
| – | – | ﹤0.01% | 1091 |
|
|
2023
Q2 | $21K | Sell |
515
-56
| -10% | -$2.15K | ﹤0.01% | 1102 |
|
|
2023
Q1 | $20K | Hold |
571
| – | – | ﹤0.01% | 1076 |
|
|
2022
Q4 | $22K | Buy |
571
+43
| +8% | +$1.81K | ﹤0.01% | 1079 |
|
|
2022
Q3 | $23K | Hold |
528
| – | – | ﹤0.01% | 1095 |
|
|
2022
Q2 | $20K | Buy |
528
+116
| +28% | +$4.37K | ﹤0.01% | 1114 |
|
|
2022
Q1 | $15K | Hold |
412
| – | – | ﹤0.01% | 1123 |
|
|
2021
Q4 | $13K | Sell |
412
-71
| -15% | -$2.23K | ﹤0.01% | 1137 |
|
|
2021
Q3 | $16K | Buy |
483
+204
| +73% | +$7.69K | ﹤0.01% | 1116 |
|
|
2021
Q2 | $11K | Sell |
279
-5,497
| -95% | -$215K | ﹤0.01% | 1044 |
|
|
2021
Q1 | $260K | Buy |
5,776
+16
| +0.3% | +$892 | ﹤0.01% | 902 |
|
|
2020
Q4 | $326K | Sell |
5,760
-531
| -8% | -$26.5K | ﹤0.01% | 849 |
|
|
2020
Q3 | $299K | Buy |
6,291
+43
| +0.7% | +$2.39K | ﹤0.01% | 809 |
|
|
2020
Q2 | $295K | Hold |
6,248
| – | – | 0.01% | 678 |
|
|
2020
Q1 | $295K | Buy |
6,248
+489
| +8% | +$27.3K | ﹤0.01% | 776 |
|
|
2019
Q4 | $348K | Sell |
5,759
-101
| -2% | -$6.02K | ﹤0.01% | 805 |
|
|
2019
Q3 | $351K | Buy |
5,860
+20
| +0.3% | +$1.3K | ﹤0.01% | 768 |
|
|
2019
Q2 | $375K | Buy |
5,840
+4,965
| +567% | +$351K | ﹤0.01% | 750 |
|
|
2019
Q1 | $71K | Sell |
875
-15
| -2% | -$968 | ﹤0.01% | 936 |
|
|
2018
Q4 | $48K | Buy |
890
+200
| +29% | +$10.2K | ﹤0.01% | 930 |
|
|
2018
Q3 | $36K | Hold |
690
| – | – | ﹤0.01% | 976 |
|
|
2018
Q2 | $29K | Hold |
690
| – | – | ﹤0.01% | 996 |
|
|
2018
Q1 | $30K | Buy |
+690
| New | +$35.1K | ﹤0.01% | 974 |
|
|
2016
Q3 | – | Sell |
-2,800
| Closed | -$65K | – | 981 |
|
|
2016
Q2 | $65K | Hold |
2,800
| – | – | ﹤0.01% | 857 |
|
|
2016
Q1 | $113K | Hold |
2,800
| – | – | ﹤0.01% | 788 |
|
|
2015
Q4 | $173K | Hold |
2,800
| – | – | ﹤0.01% | 702 |
|
|
2015
Q3 | $113K | Buy |
2,800
+200
| +8% | +$10.4K | ﹤0.01% | 797 |
|
|
2015
Q2 | $150K | Buy |
2,600
+300
| +13% | +$19.1K | ﹤0.01% | 783 |
|
|
2015
Q1 | $146K | Buy |
+2,300
| New | +$156K | ﹤0.01% | 741 |
|
Other funds holding IONS
VPM
VCM
Daiwa Securities Group's IONS Position: Q1 2026 in Review
Daiwa Securities Group sold out of Ionis Pharmaceuticals (IONS) in Q1 2026, closing a stake of 481 shares — an estimated $38K sold.
Daiwa Securities Group first reported a position in IONS in Q1 2015 and held it in 38 quarters. The position peaked at $1.62M in Q3 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Daiwa Securities Group reported no remaining Ionis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 481 Ionis Pharmaceuticals shares in Q1 2026, an estimated $38K.
- Daiwa Securities Group first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 38 quarters.
- Daiwa Securities Group's Ionis Pharmaceuticals position peaked at $1.62M in Q3 2025.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.